ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

mTOR Inhibitors Enhance Antitumor Activity of Liver Resident NK Cells

J. Saparbay, Y. Tanaka, A. Seidakhmetov, H. Ohdan

Gastroenterology and transplant Surgery, Hiroshima University, Hiroshima, Japan

Meeting: 2019 American Transplant Congress

Abstract number: C26

Keywords: Liver, Lymphocyte activation, Mice, Tumor recurrence

Session Information

Date: Monday, June 3, 2019

Session Name: Poster Session C: Innate Immunity; Chemokines, Cytokines, Complement

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • The Beneficial Effects of mTOR Inhibitors on Liver Resident Natural Killer Cells.
  • Mesenchymal Stem Cells Suppress Cytotoxic Activity of Natural Killer Cells in Islet Cell Transplantation

*Purpose: The immunosuppressive regimen currently used after organ transplantation reduces adaptive components. Therefore, the innate immune cells play pivotal roles in immune surveillance and defense against microbes and neoplastic cells after transplantation. Although the mTOR inhibitor (mTORi) is known as an immunosuppressive drug as well as a molecular targeting anti-cancer drug, its effects on innate immune cells is unclear. In this study, we analyzed the influence of mTORi on natural Killer (NK) cell subpopulations in mice.

*Methods: C57/BL6 mice were treated by intraperitoneal injection of mTORi in three different dose(0-0.25mg/kg) for 7 days. Twenty four hours after the last injection, liver mononuclear cells (LMNCs), splenocytes and peripheral blood (PB) mononuclear cells were collected. The proportion of NK cells and various functional molecules on NK cells were analyzed by flow cytometry. The cytotoxic activity of liver NK cells against hepatocellular carcinoma was analyzed by 51Cr release assay.

*Results: The proportion of TCR–NK1.1+NK fraction in LMNCs did not differ in both mTORi-treated and -untreated groups (11.0±0.3% vs 11.3±1.6%, respectively). However, mTORi significantly upregulated the expression level of TRAIL on liver NK cells in dose dependency (26.2±2.0 in 0.0125 mg/kg dose group, 27.0±2.0 in 0.0250 mg/kg dose group, 25.6±1.0 in 0.25 mg/kg dose group vs 18.5±4.76 in untreated, p=0.05, p= 0.02, p =0.03 respectively). mTORi treatment increased slightly the immature NK 1.1+ TCR β – CD11b – CD 27– TRAIL + cell subset in the liver, notably that TRAIL expression was increased on this distinct Liver NK cells only (MFI TRAIL was 373.3±2.3 in control group vs 587.2±15.6 in treated group), while TRAIL expression on other subsets were not affected .The proportion of NK cells, expression of their activation markers in the spleen were not affected by mTORi treatment. Liver NK cells from mTORi treated mice showed significantly higher cytotoxicity against TRAIL-sensitive Hepa1-6 cells (30.1% ± 13.0 vs 13.5 %± 6.0, p=0.009). Cytotoxicity against TRAIL resistant YAC-1 mouse lymphoma was also enhanced after mTORi treatment (53.6 % ± 4.4 vs 39.9% ± 1.2).

*Conclusions: mTOR inhibitor has ability to enhance liver resident NK cell activity . This result suggests that mTOR inhibitor might be useful to maintain anti-microbe and anti-tumor immunity even under immunosuppressive condition after transplantation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Saparbay J, Tanaka Y, Seidakhmetov A, Ohdan H. mTOR Inhibitors Enhance Antitumor Activity of Liver Resident NK Cells [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/mtor-inhibitors-enhance-antitumor-activity-of-liver-resident-nk-cells/. Accessed January 25, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.